- Home
- HBAN vs LH Comparison
HBAN vs LH Comparison
Compare HBAN & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HBAN | LH |
|---|---|---|
| Founded | 1866 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.0B | 21.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HBAN | LH |
|---|---|---|
| Price | $17.75 | $254.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 12 |
| Target Price | $19.32 | ★ $301.33 |
| AVG Volume (30 Days) | ★ 24.1M | 660.3K |
| Earning Date | 01-16-2026 | 02-05-2026 |
| Dividend Yield | ★ 3.50% | 1.13% |
| EPS Growth | 38.74 | ★ 98.36 |
| EPS | 1.43 | ★ 10.19 |
| Revenue | $7,502,000,000.00 | ★ $13,765,300,000.00 |
| Revenue This Year | $20.87 | $10.82 |
| Revenue Next Year | $30.73 | $4.44 |
| P/E Ratio | ★ $12.41 | $24.98 |
| Revenue Growth | ★ 12.14 | 8.28 |
| 52 Week Low | $11.92 | $209.38 |
| 52 Week High | $18.04 | $293.72 |
Technical Indicators
Market Signals| Indicator | HBAN | LH |
|---|---|---|
| Relative Strength Index (RSI) | 65.85 | 41.22 |
| Support Level | $17.51 | $250.90 |
| Resistance Level | $17.95 | $255.42 |
| Average True Range (ATR) | 0.30 | 4.33 |
| MACD | -0.01 | -0.55 |
| Stochastic Oscillator | 78.05 | 21.74 |
Price Performance
Historical ComparisonAbout HBAN Huntington Bancshares Incorporated
Huntington is a regional US bank with around $208 billion in assets and has a large presence, particularly in the Midwestern market. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.
About LH Laboratory Corporation of America Holdings
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.